On September 2, 2026 Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a late-stage clinical immunology company pioneering transformative therapies for people with neurologic autoimmune diseases, reported that company management will present at the following upcoming conferences:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2026 Wells Fargo Healthcare Conference
Format: Fireside chat and investor meetings
Date: Wednesday, September 9th, 2026
Time: 4:30 p.m. ET

Morgan Stanley 24th Annual Global Healthcare Conference
Format: Fireside chat and investor meetings
Date: Monday, September 14th, 2026
Time: 4:05 p.m. ET

H.C. Wainwright 28th Annual Global Investment Conference
Format: Fireside chat and investor meetings
Date: Tuesday, September 15th, 2026
Time: 11:30 a.m. ET

Live webcasts of the presentations may be accessed via the Investors section of the Kyverna website at ir.kyvernatx.com. Archived replays of all events will be available on the website for approximately 90 days following the conference.

(Press release, Kyverna Therapeutics, SEP 2, 2026, View Source [SID1234670540])